Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics

NIDA Home > Publications > Research Monographs >    

Imaging Techniques in Medications Development: Preclinical and Clinical Aspects



NIDA Research Monograph, Number 138 [Printed in 1994]

Get Adobe Reader This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph138.pdf - Imaging Techniques in Medications Development: Preclinical and Clinical Aspects (1.7 MB)


Table of Contents

PET, SPECT, and Probes in Drug Design and Development-----1
Henry N. Wagner, Jr.

Positron Emission Tomography in Studies of Drug Abuse-----15
Edythe D. London

Imaging Brain Function in Animals To Understand Drugs of Abuse and Potential Pharmacotherapies-----25
M.F. Piercey

Brain-Imaging Studies of the Combined Use of Cocaine and Alcohol and of the Pharmacokinetics of Cocaethylene-----41
Nora D. Volkow and Joanna S. Fowler

Positron Emission Tomography of Cocaine Binding Sites on the Dopamine Transporter-----57
Bertha K. Madras, David R. Elmaleh, Peter C. Meltzer, Anna Y. Liang, Gordon L. Brownell, and Anna-Liisa Brownell

Metabolic Mapping Methods for the Identification of the Neural Substrates of the Effects of Novel Tropane Analogs-----71
Linda J. Porrinno, Lisa Williams-Hemby, and Huw M.L. Davies

Noninvasive Evaluation of the Sympathetic Nervous System of the Heart by Nuclear Imaging Procedures-----85
Markus Schwaiger, James C. Sisson, and Donald Wieland

Development of PET/SPECT Ligands for the Serotonin Transporter-----111
Ursula Scheffel, Robert F. Dannals, Makiko Suehiro, George A. Ricaurte, F. Ivy Carroll, Michael J. Kuhar, and Henry N. Wagner, Jr.

SPECT Imaging of Dopamine and Serotonin Transporters in Nonhuman Primate Brain-----131
Marc Laruelle, Ronald M. Baldwin, and Robert B. Innis

Cerebra Blood Flow Changes With Acute Cocaine Intoxication: Clinical Correlations With SPECT, CT, and MRI-----161
I. Mena, R.J. Giornbetti, B.L. Miller, K. Garrett, J. Villanueva-Meyer, C. Mody, and M.A. Goldberg

An Introduction to Magnetic Resonance Methods for Clinical Research-----175
Gerald G. Blackwell




NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version



National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, July 22, 2008. The U.S. government's official web portal